Clinical Trial Update: Arterial Vascular Effects of Estetrol-drospirenone Combined Oral Contraceptive Pill [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating arterial vascular effects of estetrol-drospirenone combined oral contraceptive pill; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• estetrol-drospirenone combined oral contraceptive pill

Snippet

Sponsor: Dr. Hang Wun Raymond Li | Conditions: Contraception | Phase 3 | Status: NOT_YET_RECRUITING